Creganna-Tactx Medical has announced today that Robert B. Hance will join the company as Chief Executive Officer in September 2013, taking over the role from Helen Ryan who has held the position for the last eight years. Robert ...
Tags: medicine, Creganna-Tactx Medical
US-based medical technology provider Boston Scientific said it is launching the new polymer-based drug-eluting stent (DES) system in the European market as the product has obtained CE mark approval. The Promus Premier everolimus-eluting ...
Abbott has initiated a ABSORB III clinical trial of its drug eluting bioresorbable vascular scaffold (BVS) device, designed for the treatment of coronary artery disease patients. The Absorb device, which includes a multi-link stent ...
Tags: Abbott, ABSORB III clinical trial, drug eluting BVS, treatment
Abbott has obtained regulatory approval for its XIENCE Xpedition Everolimus Eluting Coronary Stent system,designed for improving coronary artery luminal diameter in patients with symptomatic heart disease due to de novo native coronary ...
Tags: Abbott, FDA, Drug Eluting System, XIENCE, symptomatic heart disease
Global healthcare firm Abbott's everolimus eluting coronary stent system has been accorded with CE Mark in Europe. The XIENCE Xpedition everolimus eluting coronary stent system, which is used to treat coronary artery disease, provides ...
Tags: Abbott, CE mark, coronary stent system, coronary artery disease